Virpax Pharmaceuticals Announces Extension Of Cooperative Research And Development Agreement With US Army Institute Of Surgical Research
Portfolio Pulse from Bill Haddad
Virpax Pharmaceuticals has extended its cooperative research and development agreement with the US Army Institute of Surgical Research. The extension will allow for continued collaboration on the development of non-opioid pain management solutions.
October 12, 2023 | 12:08 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
The extension of the research agreement between Virpax Pharmaceuticals and the US Army Institute could potentially lead to the development of new non-opioid pain management solutions, which could positively impact the company's stock.
The extension of the research agreement signifies continued collaboration between Virpax Pharmaceuticals and the US Army Institute. This could potentially lead to the development of new non-opioid pain management solutions, which are in high demand due to the opioid crisis. This could increase the company's market share and positively impact its stock price.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100